crystal growth inhibitors prevention l-cystine kidney stones molecular design 
crystallization l-cystine critical step pathogenesis cystine kidney stones treatments disease somewhat effective often lead adverse side effects real-time situ atomic force microscopy afm reveals l-cystine dimethylester l-cdme l-cystine methylester l-cme dramatically reduce growth velocity six symmetry-equivalent {} steps specific binding crystal surface frustrates attachment l-cystine molecules l-cdme l-cme produce l-cystine crystals different habits reveal distinct binding modes crystal surfaces afm observations mirrored reduced crystal yield crystal size presence l-cdme l-cme collectively suggesting new pathway prevention l-cystine stones rational design crystal growth inhibitors 
